Although there was a trend for enhanced intra-hepatic CD8+ T-cells producing IFN-γ in response to HCV peptides in therapy-naive co-infection compared to HCV mono-infection, this was not found to be statistically significant. The gene discussed is CD8A; the disease is infection.